Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

2(40.0%)

5Total

N/A(3)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05208216Not ApplicableCompleted

Neuromuscular Stimulation Versus Intermittent Compression for Venous Thromboembolism Prophylaxis in Critical Care

Role: collaborator

NCT04901988Phase 2Terminated

Circulating Tumour DNA guidEd Therapy for Stage IIB/C mElanoma After surgiCal resecTION

Role: collaborator

NCT05670197Completed

Service User and Staff Views on Digital Remote Monitoring for Psychosis

Role: lead

NCT04488861Active Not Recruiting

The START Clinic: a Feasibility Study

Role: lead

NCT03293147Not ApplicableCompleted

OUTREACH: Urine Analysis and Antihypertensive Treatment

Role: collaborator

NCT03808441Phase 2Unknown

CAcTUS - Circulating Tumour DNA Guided Switch

Role: collaborator

NCT04797208Not ApplicableUnknown

Remote Glucose Monitoring in Hospital Settings

Role: collaborator

NCT03564457Completed

20K Distributed Learning Challenge

Role: collaborator

NCT03558529Completed

Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis Relapse

Role: lead

All 9 trials loaded